SEC Form 4 · accession 0001104659-16-134622
Vitae Pharmaceuticals, Inc · VTAE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel M Junius
Director
Period of report
Jul 27, 2016
Accepted (ET)
Jul 27, 2016 · 5:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001157602
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $11.37 | Jul 27, 2016 | A | 20,000 | A | — | Jul 26, 2026 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1The option will vest in quarterly installments over three years following 7/27/2016.